Girish Mohan, MD
Dermatology · Tulsa, OKNPI 1093193161
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,561, more than ten times the $97 reported in 2019. That places this record below the midpoint for dermatology clinicians in OK, where the typical reported total is $4,319.
Across 157 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$374
- Sanofi$331
- Lilly USA, LLC$255
- Johnson & Johnson$252
- UCB, Inc.$238
- Amgen$229
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,90097%
- Education$813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $374 |
| Sanofi | 16 | $331 |
| Lilly USA, LLC | 13 | $255 |
| Johnson & Johnson | 14 | $252 |
| UCB, Inc. | 20 | $238 |
| Amgen | 11 | $229 |
| Novartis | 10 | $203 |
| AbbVie | 9 | $186 |
| Arcutis Biotherapeutics, Inc. | 13 | $147 |
| Pfizer | 7 | $131 |
| Sun Pharmaceutical Industries Inc. | 5 | $105 |
| Biocon Biologics Inc | 3 | $74 |
| LEO Pharma Inc. | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $64 |
| Mimedx Group, Inc. | 2 | $60 |
| Organon | 4 | $53 |
| Dermira, Inc. | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Almirall LLC | 2 | $32 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $30 |
| Incyte Corporation | 1 | $27 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,981 in reported general payments places this provider in the 45th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $80,191 |
| Dupixent PenDupilumab | 20 | $74,152 |
| Fluorouracil | 73 | $5,804 |
| Ketoconazole | 345 | $5,595 |
| Tacrolimus | 24 | $4,189 |
| Calcipotriene | 21 | $3,002 |
| CiclopiroxCiclopirox Olamine | 61 | $2,791 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 101 | $2,583 |
| Mupirocin | 346 | $2,111 |
| Metronidazole | 47 | $1,938 |
| Clobetasol Propionate | 33 | $1,868 |
| Fluocinonide | 44 | $1,768 |
| Tretinoin | 39 | $1,486 |
| Triamcinolone Acetonide | 162 | $978 |
| Clindamycin Phosphate | 21 | $859 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tulsa
- George MonksTulsa$530K
- Jeff AlexanderTulsa$41K
- Johnathan LedetTulsa$37K
- John AshleyTulsa$24K
- Alison FischerTulsa$18K
- Mark LehmanTulsa$17K
- Kelli LovelaceTulsa$14K
- Bernard RobinowitzTulsa$14K
- Christina KendrickTulsa$13K
- Ashwini VaidyaTulsa$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.